STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Shattuck Labs, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$5.37−0.05 (-0.92%)
Close on Oct 19, 2026
- Market cap
- $696.91M
- P/E (TTM)
- –
- Dividend yield
- –
Shattuck Labs, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | % of revenue | YoY |
|---|---|---|---|---|---|
| Related party license revenue | $1.00M | $0 | – | 100.0% | – |
| Collaboration revenue: | $0 | $5.72M | – | 0.0% | -100.0% |
By region
From the segment and revenue-disaggregation notes of Shattuck Labs's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.